BB&T Securities’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $2.43M | Buy |
54,448
+682
| +1% | +$30.5K | 0.02% | 528 |
|
2019
Q2 | $2.22M | Buy |
53,766
+1,510
| +3% | +$62.3K | 0.02% | 560 |
|
2019
Q1 | $2.11M | Sell |
52,256
-122,661
| -70% | -$4.96M | 0.02% | 560 |
|
2018
Q4 | $6.64M | Sell |
174,917
-52,923
| -23% | -$2.01M | 0.07% | 313 |
|
2018
Q3 | $9.01M | Sell |
227,840
-48,377
| -18% | -$1.91M | 0.09% | 295 |
|
2018
Q2 | $9.7M | Sell |
276,217
-19,402
| -7% | -$681K | 0.1% | 263 |
|
2018
Q1 | $10.3M | Sell |
295,619
-3,376
| -1% | -$118K | 0.12% | 237 |
|
2017
Q4 | $10.4M | Sell |
298,995
-574
| -0.2% | -$19.9K | 0.13% | 214 |
|
2017
Q3 | $10.1M | Buy |
299,569
+38,428
| +15% | +$1.3M | 0.14% | 209 |
|
2017
Q2 | $8.9M | Buy |
261,141
+14,241
| +6% | +$485K | 0.13% | 220 |
|
2017
Q1 | $7.69M | Buy |
246,900
+22,728
| +10% | +$708K | 0.1% | 228 |
|
2016
Q4 | $7.37M | Hold |
224,172
| – | – | 0.11% | 220 |
|
2016
Q3 | $7.37M | Buy |
224,172
+73,314
| +49% | +$2.41M | 0.11% | 214 |
|
2016
Q2 | $4.55M | Buy |
150,858
+31,642
| +27% | +$955K | 0.07% | 283 |
|
2016
Q1 | $3.36M | Buy |
119,216
+45,556
| +62% | +$1.28M | 0.06% | 304 |
|
2015
Q4 | $2.5M | Sell |
73,660
-3,408
| -4% | -$116K | 0.05% | 299 |
|
2015
Q3 | $2.45M | Buy |
77,068
+35,626
| +86% | +$1.13M | 0.05% | 296 |
|
2015
Q2 | $1.32M | Buy |
41,442
+17,292
| +72% | +$551K | 0.03% | 459 |
|
2015
Q1 | $8.26M | Sell |
24,150
-4,612
| -16% | -$1.58M | 0.02% | 576 |
|
2014
Q4 | $10.1M | Sell |
28,762
-542
| -2% | -$191K | 0.02% | 497 |
|
2014
Q3 | $10.5M | Sell |
29,304
-8,170
| -22% | -$2.92M | 0.02% | 457 |
|
2014
Q2 | $13.9M | Sell |
37,474
-205,488
| -85% | -$76.3M | 0.03% | 364 |
|
2014
Q1 | $78.8M | Sell |
242,962
-8,386
| -3% | -$2.72M | 0.2% | 97 |
|
2013
Q4 | $74.6M | Buy |
251,348
+9,548
| +4% | +$2.83M | 0.21% | 104 |
|
2013
Q3 | $62.8M | Sell |
241,800
-11,744
| -5% | -$3.05M | 0.19% | 104 |
|
2013
Q2 | $60K | Buy |
+253,544
| New | +$60K | 0.2% | 100 |
|